The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte.
Porcine fetal islet-like cell clusters (ICC) or isolated rat islets were implanted under the kidney capsule of normoglycemic rats. The animals were sacrificed 1, 3, 6, 12, or 24 days after transplantation, and a detailed morphological and phenotypic characterization of the different cellular subtypes infiltrating the xenograft was performed and compared with the rejection of allogeneic islets. In xenograft rejection a progressive infiltration of large, polygonal, macrophage-like cells, which with time became the dominating cellular subtype, occurred. These cells expressed the CD4 antigen and the macrophage-specific ED1 antigen. From day 6 and onward, a majority of the macrophage-like cells also expressed the CD8 antigen and the macrophage-specific differentiation antigen ED2. T lymphocytes, defined by their TCR alpha/beta or CD2 expression, were found in low numbers and mainly in the periphery of the graft. At the later stages of xenorejection a substantial number of eosinophilic granulocytes were also found. The allograft rejection, on the contrary, was characterized by a progressive infiltration of T lymphocytes, which with time became the dominating cellular subtype. No clear immunoglobulin or complement deposition was seen in the transplants before day 12, when IgG deposition was found in central necrotic areas of the xenograft. Previous experiments in rodents have underlined the crucial importance of CD4 positive cells in the xenograft rejection process. However, in none of these studies it was conclusively demonstrated that the CD4-expressing cells were T lymphocytes. The presence of CD4-expressing macrophages heavily infiltrating the porcine xenograft seen in our study may thus be in agreement with previous studies in which the anti-CD4 reactive cells were erroneously designated T lymphocytes. Interestingly, the findings in xenograft rejection in the present study have striking similarities with the defense mechanisms active against infections by large parasites such as helminths.
Wallgren
A C
AC
Department of Clinical Immunology and Transfusion Medicine, University Hospital, Uppsala, Sweden.
Karlsson-Parra
A
A
Korsgren
O
O
D000818:Animals; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D015704:CD4 Antigens / Q000032:analysis*; D003165:Complement System Proteins / Q000378:metabolism; D006084:Graft Rejection; D007136:Immunoglobulins / Q000378:metabolism; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008264:Macrophages / Q000276:immunology*; D008297:Male; D051381:Rats; D011920:Rats, Inbred WF; D017207:Rats, Sprague-Dawley; D013552:Swine; D013601:T-Lymphocytes / Q000276:immunology*; D014183:Transplantation, Heterologous / Q000276:immunology*
D015214:Antigens, Differentiation, Myelomonocytic; D015704:CD4 Antigens; D007136:Immunoglobulins; D003165:Complement System Proteins